News
Empowering the biopharma industry with field-leading foundation models.
Recent News
Blog
|
October 29, 2026
Steering Discrete Diffusion: Design Choices for Feedback-Efficient Molecular Optimization
Blog
|
June 3, 2026
Zero-shot Pearl System Surpasses All Cofolding Models on OpenBind
Press
|
May 20, 2026
Forbes: Inside Incyte’s $120 Million AI For Drug Development Deal
Forbes
Blog
|
June 10, 2026
Genesis Model Distillation
Press Release
|
May 20, 2026
Incyte and Genesis Molecular AI Expand Collaboration
Press
|
December 2, 2025
Genesis Molecular AI Appoints Sergey Edunov as Senior Vice President of Foundation Models, Further Strengthening Leadership in Machine Learning
Business WIre
Blog
|
October 28, 2025
Introducing Pearl: The Next Generation Foundation Model for Drug Discovery
Press
|
October 28, 2025
Genesis Molecular AI Unveils Pearl
Business Wire
Join Us
Opportunities in AI and Physics Research
Our molecular AI research team is pioneering new frameworks for drug discovery, at the intersection of multi-dimensional ML models and physical simulation. See opportunities in software engineering, machine learning and computation chemistry.
Software Engineering
Machine Learning
Computational Chemistry
